4//SEC Filing
Jantzen Beth 4
Accession 0001144204-18-054170
CIK 0000744452other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 2:10 PM ET
Size
8.3 KB
Accession
0001144204-18-054170
Insider Transaction Report
Form 4
Jantzen Beth
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2018-10-14−4,167→ 0 totalExercise: $5.13Exp: 2018-10-14→ Common Stock (4,167 underlying) - Award
Stock Option (right to buy)
2018-10-14+4,167→ 4,167 totalExercise: $5.13From: 2018-10-14Exp: 2023-10-14→ Common Stock (4,167 underlying)
Footnotes (1)
- [F1]The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from October 14, 2018 to October 14, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on October 14, 2013 and provided for vesting (i) with respect to 25% of the underlying shares on the anniversary of the original grant date and (ii) with respect to the remaining underlying shares, ratably each anniversary thereafter until fully vested on the fourth anniversary of the original date of grant.
Documents
Issuer
APPLIED DNA SCIENCES INC
CIK 0000744452
Entity typeother
Related Parties
1- filerCIK 0001633940
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 2:10 PM ET
- Size
- 8.3 KB